Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades63
MXCT
Live RNS
MXCT Share
Charts
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MXCT Company
Research
MXCT Company
Timeline
- There is currently no data for MXCT
MaxCyte News
MaxCyte revenue grows in 2022, expects further revenue climb in 2023
(Alliance News) - MaxCyte Inc on Tuesday announced a higher revenue for 2022, and said it anticipates revenue to grow further during 2023.
MaxCyte flags 2022 revenue growth, sets new guidance
(Sharecast News) - Cell engineering technology company MaxCyte said in an update on Tuesday that it was expecting full-year 2022 total revenue of $44....
TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
MaxCyte signs strategic platform licence with Catamaran Bio
(Alliance News) - MaxCyte Inc on Wednesday said it signed a strategic platform licence with biotechnology company Catamaran Bio Inc.
MaxCyte signs strategic platform licence with Catamaran Bio
(Sharecast News) - Commercial cell engineering company MaxCyte announced the signing of a strategic platform licence (SPL) with Catamaran Bio on Wedne...
TRADING UPDATES: MaxCyte in deal; Angus to resume Saltfleetby drilling
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
MaxCyte inks deal with South Korea's Curamys
(Sharecast News) - Cell engineering technology company MaxCyte announced a strategic platform licence with South Korea-based biotechnology specialist ...
Follow the stocks
